Page last updated: 2024-10-27

gabexate and Abruptio Placentae

gabexate has been researched along with Abruptio Placentae in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Abruptio Placentae: Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumura, T1
Aoyama, Y1
Ichihara, H1
Koh, S1
Mugitani, A1
Hayakawa, H1
Yukioka, K1
Kinoshita, D1
Nakagawa, M1
Yamazaki, N1

Other Studies

1 other study available for gabexate and Abruptio Placentae

ArticleYear
[Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:2

    Topics: Abruptio Placentae; Adult; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female

2011